Andrea Carta Mantiglia

Sales & Marketing

Andrea Carta Mantiglia, partner and lead of the Healthcare & Life Sciences Focus Team at Italian law firm BonelliErede, discusses M&A in Europe.

News

Spero has licensed rights to an anti-CD40L antibody developed by China's Innovent, in a $1.1bn deal that signals a shift away from antimicrobial R&D.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.